Primary prevention of cardiovascular disease using validated risk scores: A systematic review

Journal of the Royal Society of Medicine

Volumn 105, Issue 8, 2012, Pages 348-356

  Willis, Andrew ^a   Davies, Melanie ^b   Yates, Thomas ^b   Khunti, Kamlesh ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COMPUTER RISK SCORING SYSTEM; DATA BASE; FRAMINGHAM RISK SCORE; HEART INFARCTION PREVENTION; HUMAN; INFARCTION SCORE; INFORMATION PROCESSING; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MORTALITY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RISK FACTOR; SCORING SYSTEM; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH PROMOTION; INTERVENTION STUDY; MALE; MIDDLE AGED; NORTH AMERICA; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK ASSESSMENT; SCANDINAVIA; SURVIVAL; UNITED KINGDOM; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; MORBIDITY; RISK REDUCTION; SMOKING; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; GREAT BRITAIN; HEALTH PROMOTION; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SCANDINAVIA; SURVIVAL ANALYSIS; YOUNG ADULT;

CHOLESTEROL; GLUCOSE;

EID: 84865498438     PISSN: 01410768     EISSN: 17581095     Source Type: Journal    
DOI: 10.1258/jrsm.2012.110193     Document Type: Article

References (30)

1. World Health Organisation. World Health Report 2002. Reducing Risks and Promoting Healthy Life. Geneva, 2002
2. American Heart Association Statistics Writing Group. Heart Disease and Stroke Statistics–2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146
3. World Health Organisation. European cardiovascular disease statistics 2008 Chapter 1: Mortality. Geneva, 2008
4. British Heart Foundation. European Cardiovascular Disease Statistics. 2005 Edition
5. Ebrahim S, Beswick A, Burke M, Davey Smith G. Multiple Risk Factor Interventions for Primary Prevention of Coronary Heart Disease. Cochrane Database of Systematic Reviews 2006;Issue 4:CD001561
6. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92:1752-59
7. Anderson K, Odell P, Wilson P, Kannel W. Cardiovascular disease risk profiles. American Heart Journal 1991;121:293-98
8. Assman G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10 year follow up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310-15
9. Wilson PF, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor catagories. Circulation 1998;97:1837-47
10. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009;338:b880
11. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008;336:598
12. Department of Health. Putting prevention first–vascular checks: risk assessment and management. Annex 1: options stage impact assessment for vascular risk assessments, 2008
13. Patel K, Minhas R, Gill P, Khunti K, Clayton R. Vascular risk checks in the UK: strategic challenges for implementation. Heart 2009;95:866-67
14. Kulzer BH, Gorges N, Schwarz D, Haak P. Prevention of Diabetes Self Management Programme (PREDIAS): Effects on Weight, Metabolic Risk Factors and behavioural Outcomes. Diabetes Care 2009;32:1143-46
15. Spijkerman A, Dekker J, Nijpels G, et al. Microvascular Complications at Time of Diagnosis of Type 2 Diabetes Are Similar Among Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: The Hoorn Screening Study. Diabetes Care 2003;26:2604-2608
16. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]: The Cochrane Collaboration, 2009
17. Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ : Canadian Medical Association Journal 2007;177:859-65
18. Meland E, lærum E, Ulvik R. Effectivness of two preventitive interventions for coronary heart disease in primary care. Scandinavian Journal of Primary Health Care 1997;15:57-63
19. Ketola E, Mäkelä M, Klockars M. Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care. The British Journal of General Practice: the Journal of the Royal College of General Practitioners 2001:291-4
20. Multiple risk factor intervention trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982;248:1465-77
21. Wood D, Kinmouth A, Davies G, et al. Randomised Controlled Trial Evaluating Cardiovascular Screening and Intervention in General Practice: principal results of British Family Heart Study. BMJ 1994;308:313-20
22. Kornitzer M, Rose G. WHO European Collaborative Trial of multifactorial prevention of coronary heart disease. Prev Med 1985;14:272-8
23. Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ. Personalised Risk Communuication for Informed Decision Making about Taking Screening Tests (Review). The Cochrane Library 2009;Issue 1
24. Collins R, MacMahon S. Blood pressure, antihypertensive treatment and the risk of stroke and coronary heart disease. British Medical Bulletin 1994;50:272-98
25. Scandinavian Simvastatin Survival Study Group. Randomised trial of lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-89
26. Frank E. Benefits of Stopping Smoking. West J Med 1993;159:83-86
27. Khunti K, Ganguli S, Baker R, Lowy A. Features of primary care associated with variations in process and outcome of care of people with diabetes. British Journal of General Practice 2001;51:356-60
28. Hippisley-Cox J, O'Hanlon S, Coupland C. Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53,000 patients in primary care. BMJ 2004;329:1267-9
29. Vartiainen E, Puska P, Jousilahti P, Huttunen J. The success of prevention of CHD in finland. Suomen Laakarilehti 1998;53:2023-26
30. Department of Health. Putting Prevention First. Vascular checks: Risk Assesment and Managment. London, 2008